Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
Effects of Brain Beta-Amyloid on Postoperative Cognition
† Study has passed its completion date and status has not been verified in more than two years.